Noninvasive analysis of renal function in conscious mice is necessary to optimize the use of mouse models. In this study, we evaluated whether single photon emission-computed tomography (SPECT) using specific radionuclear tracers can be used to analyze changes in renal proximal tubule functions. The tracers included 99m TC-dimercaptosuccinic acid ( 99m Tc-DMSA), which is used for cortex imaging; 99m Tc-mercaptoacetyltriglycine ( 99m Tc-MAG3), used for dynamic renography; and 123 I-␤2-microglobulin, which monitors receptor-mediated endocytosis.
TRANSGENIC MOUSE STRAINS ARE widely used to investigate the structure and function of developing and mature kidneys and to model human disorders. Thus far, functional studies into disease mechanisms essentially require animal death and ex vivo investigations that are potentially limited by various factors including low fertility rates, gender effects (e.g., X-linked transmission), or limited life span in some models. These restrictions complicate the design of intervention studies and require the development of large colonies, increasing costs and raising ethical questions. To circumvent some of these limitations, efforts are being made to develop in vivo functional imaging techniques in mice. In particular, the possibility to perform quantitative and/or dynamic molecular imaging studies using high-resolution positron emission tomography (PET) or single photon emission-computed tomography (SPECT) has emerged recently (23) .
Among its numerous applications, SPECT may be useful for noninvasive investigation of renal function in the mouse by means of dynamic imaging, parenchymal scanning, and quantification of filtration, secretion, and reabsorption events (8) . In particular, the possibility to use different radiotracers for SPECT imaging provides the opportunity to investigate various transport processes taking place in the proximal tubule (PT), a segment that plays a paramount role in homeostasis ( Fig. 1 ). Diseases causing PT dysfunction are associated with life-threatening complications, including electrolyte and acidbase disorders, protein and amino acid imbalance, as well as abnormal handling of numerous endogenous and exogenous compounds.
To evaluate the technical possibilities of dynamic molecular imaging in vivo, we have used a SPECT system (26) to investigate the transport functions of the PT including apical and basolateral uptake and apical secretion. We evaluated these parameters in control mice, mice with restricted kidney infarction, and mice with congenital or acquired PT dysfunction (renal Fanconi syndrome). In particular, we used Clcn5 knockout (KO; Clcn5 Y/Ϫ ) mice that are characterized by generalized PT dysfunction and low-molecular-weight (LMW) proteinuria due to defective receptor-mediated endocytosis (7) and represent a well-established model for Dent's disease (28) . We also used a mouse model of acquired, reversible PT injury induced by cisplatin (9) to evaluate the potential recovery over time.
To avoid the potential deleterious effects of general anesthesia, SPECT imaging was performed in conscious mice, using three well-established renal radionuclear tracers (Fig. 1) . 99m Tc-mercaptoacetyltriglycine ( 99m Tc-MAG3), which is secreted into the urine following basolateral uptake by PT cells, is regarded as the best available tubular marker for dynamic renography (12) . Dimercaptosuccinic acid ( 99m Tc-DMSA), which accumulates in the renal cortex by a basolateral uptake in the epithelial cells lining the pars recta (S3 segment), is used for cortex imaging (16, 25) . Finally, 123 I-␤ 2 -microglobulin is a reference tracer for assessing the receptor mediated endocytosis of ultrafiltered LMW proteins by PT cells (7) . (28) and had similar body weight, hematocrit, and plasma creatinine levels than wild-type littermates in this age group. Restricted kidney infarction was induced in C57 mice by clamping the superior pole of the organ for 30 min under anesthesia. A model of partial or full recovery of acute PT injury was obtained by a single injection of either vehicle (saline) or cisplatin (12 mg/kg BW ip) in C57 mice with follow-up for 2 wk (9). Mice were housed individually in metabolic cages to assess overnight urine flow rate and renal function during the cisplatin protocol. All procedures were performed in accordance with National Institutes of Health guidelines for the care and use of laboratory animals, and with the approval of the Committee for Animal Rights of the Université catholique de Louvain Medical School.
MATERIALS AND METHODS

Animals
Radiotracers. Human ␤ 2-microglobulin (␤2M; Sigma, St. Louis, MO) was iodinated with 123 I-Na ϩ (GE Healthcare, Brussels, Belgium) and Iodobeads (Pierce, Aalst, Belgium) as previously described (7) (purity in excess of 92% trichloroacetic acid-precipitable). Dimercaptosuccinic acid (TechneScan DMSA) or mercaptoacetyltriglycine (TechneScan MAG3) from Tyco HealthCare (Mechelen, Belgium) were radiolabeled with 99m Tc-Na-pertechnetate (Tyco HealthCare) following the standard procedure. The physical half-life of 123 I is 13 h and that of 99m Tc is 6 h. Radiopharmaceutical purity was Ͼ99%, as confirmed by instant thin-layer chromatography. All radiotracers were diluted in saline (NaCl 0.9%) and injected (lateral caudal vein of the tail iv) in a total volume of 150 l.
SPECT system. The small-animal SPECT device (Linoview Systems, Amsterdam, The Netherlands) is made of four ␥-detectors based on pixilated CsI(Na) scintillators (5-mm thickness, 2.44 ϫ 2.44-mm crystal size). Detectors are fitted with a rake collimator equipped with an adjustable slit aperture, made of two iridium square rods (2 ϫ 2 ϫ 60-mm) (Supplemental Fig. 1 ; all supplementary material for this article is available on the journal web site). The spatial resolution of the system after reconstruction is 0.35 mm (26) .
Acquisition procedure. In a preliminary experiment, dynamic 99m Tc-MAG3 SPECT imaging was performed before and after anesthesia (ketamine, 100 g/g, Merial, Brussels, Belgium; xylazine 10 g/g, Bayer, Antwerp, Belgium) in two pairs of C57 mice. Subsequently, kinetic studies with the three radiotracers were performed on conscious Clcn5 mice placed in a plastic holder to reduce animal motion during imaging (Supplemental Fig. 1 ). The mice (pairs of Clcn5 WT vs. KO) were studied over a total period of 8 wk, with three sequential injections of DMSA, MAG3, and ␤2M on the same mice, separated by a minimal interval of 5 days.
Static SPECT was obtained hourly (acquisitions of 5 min each) during 5 h after intravenous (iv) injection of 700 Ci of 99m Tc-DMSA (n ϭ 4 pairs). At 6 h postinjection, a 30-min acquisition was performed under anesthesia to obtain high-resolution images. In two pairs of mice, the scanning was repeated 30 min after furosemide injection (10 mg/kg BW ip; final volume: 30 l). Continuous dynamic SPECT (acquisitions of 15-s each) was achieved over 30 min after iv injection of 600 Ci of 99m Tc-MAG3 (n ϭ 3 pairs) or 200 Ci 123 I-␤2-microglobulin (n ϭ 3 pairs), respectively. The linear motion of the detectors was set in such a way that the four-slit apertures would draw the narrowest rectangle possible around the animal. The distance between the actual contours and the collimator aperture was typically Fig. 1 . Transport of ␤2-microglobulin (␤2M), mercaptoacetyltriglycine (MAG3), and dimercaptosuccinic acid (DMSA) along the proximal tubule (PT). The epithelial cells lining the convoluted part (S1-S2 segments) of the PT efficiently reabsorb the low-molecular-weight ␤2M from the primitive urine (glomerular ultrafiltrate) by receptor-mediated endocytosis after interaction with the multiligand receptors megalin and cubilin. After internalization and progression along the endocytic apparatus (E), ␤2M is degraded in lysosomes (L). In addition, PT cells secrete MAG3 from the plasma into the urine. The basolateral uptake of MAG3 occurs in exchange for intracellular dicarboxylates, namely, ␣-ketoglutarate (␣-KG), through the organic anion transporter OAT1 (SLC22A6). A-KG is a key intermediate in the Krebs cycle, which enters PT cells through a Na ϩ -dicarboxylate cotransporter (NaDC; not formally identified as NaDC3; see below), whereas Na ϩ is recycled through the Na ϩ -K ϩ -ATPase. The MAG3 secretion into the lumen is mediated by the multidrug resistance protein MRP2 inserted in the apical membrane of PT cells. The Na ϩ -dependent phosphate transporter NPT1 may also be involved in MAG3 secretion. The epithelial cells lining the pars recta (S3 segment) of the PT are involved in the basolateral uptake of DMSA from peritubular capillaries, which is mediated by the Na ϩ -dicarboxylate cotransporter NaDC3 (also named SLC13A3). A limited fraction of DMSA is filtered through the glomerulus and lost in the urine. Modified from Refs. 4 and 24. ϳ3 mm. The linear acquisition generates linograms forming a complete set of tomographic data allowing the reconstruction of the activity map (27) .
Data processing. Reconstructions were performed using the maximum-likelihood expectation maximization algorithm with attenuation correction but without scatter correction or spatial resolution recovery (11) . Time-activity curves were generated.
99m Tc-MAG3 dynamic parameters were calculated using a three-compartment model, by fitting the curves to two exponentials.
The glomerular filtration rate (GFR) of 123 I-␤2-microglobulin was assessed by fitting all the organ curves (heart, kidney, thyroid, liver, spleen, bladder) by a multicompartmental model (Supplemental Fig.  2 ). The GFR can be calculated as GFR ϭ k g 1 Vp (i), where k g 1 is the glomerular uptake rate of the 123 I-␤2-microglobulin, and Vp is the plasma volume. Only the interval from 30 to 180 s postinjection was considered to avoid the effects of dilution after bolus injection, as well as 123 I-␤2-microglobulin tubular reabsorption and metabolization, respectively. All kinetic parameters of renal uptake were calculated using SigmaPlot 2000 (Systat Software, Erkrath, Germany). The plasma volume of the mice was estimated based on blood volume (8% body wt) (20) and 0.45 as average hematocrit value for the Clcn5 mice.
Autoradiography. For autoradiography, kidneys were exsanguined in situ, removed 7 min after iv injection of 620 ng/g of body weight of 125 I-␤2-microglobulin, and fixed for 6 h at 4°C in 4% formaldehyde. Ten-micrometer sections were overlaid, treated with emulsion reagent (Ilford Scientific Product, Wilrijk, Belgium), and revealed after 1 mo.
Plasma and urine analyses. Urinary creatinine (modified Jaffé method) and albumin (turbimetric method) and plasma creatinine (enzymatic determination) were measured on a Synchron CX5 analyzer (Beckman Coulter, Brea, CA), following the manufacturer's protocols (3) . The urinary excretion of the LMW Clara cell protein (CC16, 16 kDa) was measured by radioimmunoassay (7) .
Statistics. Results are expressed as means Ϯ SD. Comparisons between Clcn5
Y/ϩ and Clcn5 Y/Ϫ mice were made by Student's unpaired t-tests assuming equal variance. The significance level was set at P Ͻ 0.05. Interassay variability was calculated as variation coefficient in 6 kidneys.
RESULTS
Imaging of the kidney cortex based on static
99m Tc-DMSA uptake. 99m Tc-DMSA SPECT clearly delineated the functional renal cortex, whereas the medulla and the pelvis area (ϳ1 mm) remained silent ( Fig. 2A) . The tracer uptake was abolished over an apical area of experimental infarction, the boundaries of which correlated with the histopathological examination (Fig. 2, A and B) . Y/ϩ kidneys, insensitive to furosemide (Fig. 2, D and E) . In contrast, the cortical uptake of 99m Tc-DMSA was abolished in Clcn5 Y/Ϫ kidneys (Fig. 2 , C and E; Table 1 ), with minimal activity in the pelvis that was cleared after furosemide injection.
These results demonstrate that 99m Tc-DMSA SPECT imaging is able to delineate the functional renal cortex in the mouse, with a ϳ1-mm spatial resolution and a kinetics of uptake similar to the asymptotic curve observed in humans. Defective 99m Tc-DMSA cortical imaging is observed in cases of defective perfusion (kidney infarction) or generalized dysfunction of PT cells (Clcn5 Y/Ϫ mice).
Dynamic renography with 99m
Tc-MAG3.
99m Tc-MAG3 is considered as the best tracer for dynamic imaging of the kidney. The tracer is concentrated in PT cells by basolateral uptake, followed by secretion into the urine without intracellular metabolization. The effect of anesthesia on the 99m Tc-MAG3 uptake by wild-type (C57) mice is shown on Fig. 3 . Ketamine-xylazine anesthesia induced a significant delay in the 99m Tc-MAG3 clearance, with a delayed and higher peak of uptake, as well as a higher degree of variability than in conscious mice. The dynamic renography in conscious Clcn5 mice is shown on Fig. 4 .
The SPECT imaging of 99m Tc-MAG3 handling by wild-type Clcn5 Y/ϩ kidneys is characterized by a rapid extraction from blood (T 1/2IN , 0.4 Ϯ 0.1 min), maximal renal accumulation between 90 and 120 s after iv injection (ϳ12% of injected dose/kidney), and subsequent tubular secretion (T 1/2OUT , 4.7 Ϯ 0.5 min). Of note, the kinetic parameters of 99m Tc-MAG3 handling are not significantly affected in Clcn5 Y/Ϫ mice ( Fig.  4 ; Table 1 ).
Renal handling of 123 I-␤ 2 -microglobulin in Clcn5 mice. ␤ 2 -microglobulin is a 12-kDa protein that is ultrafiltrated and completely reabsorbed via receptor-mediated endocytosis at the apical pole of PT cells. Monitoring the endocytic uptake of ␤ 2 -microglobulin is thus considered as a faithful marker of the activity of PT cells (7) . The dynamic SPECT imaging of 123 
I-␤ 2 -microglobulin handling by wild-type Clcn5
Y/ϩ kidneys showed a rapid glomerular filtration followed by a progressive accumulation in the cortex, with maximal activity (6.4 Ϯ 0.7% of injected dose/kidney) at 7 min postinjection ( Fig. 5A ; Table  1 
Clcn5
Y/ϩ kidneys contrasting with the lack of tracer uptake in Clcn5 Y/Ϫ kidneys (Fig. 5B) . Importantly, the calculated glomerular filtration rate of 125 I-␤ 2 -microglobulin (0.22 Ϯ 0.02 ml/min), based on the first part of the curve (see Fig. 5A ), was similar in both strains of Clcn5 mice. These data demonstrate that the congenital PT dysfunction caused by the lack of ClC-5 is adequately reflected by SPECT imaging of defective renal handling of ␤ 2 -microglobulin.
Renal uptake of 123 I-␤ 2 -microglobulin: recovery after cisplatin injury. We used a model of reversible tubular toxicity induced by cisplatin, to test the potential of SPECT to provide a longitudinal assessment of acquired PT dysfunction in individual mice. The PT dysfunction, evidenced by the urinary excretion of albumin (and that of CC16, data not shown), peaked at day 5 and showed progressive recovery thereafter (Fig. 6A) . A similar profile was observed by sequential SPECT Fig. 6 . Cisplatin-induced acute kidney injury: albuminuria and 123 I-␤2-microglobulin handling. Shown are serial determination of the urinary excretion of albumin (A) and repetitive SPECT imaging of 123 I-␤2-microglobulin uptake in mice treated with cisplatin (B). The urinary excretion of albumin (baseline: 0.06 Ϯ 0.04 g/mg creatinine) peaked at day 5 (165 Ϯ 70 g/mg creatinine) and subsequently decreased toward normal values at day 11 (2.5 Ϯ 1 g/mg creatinine) and day 13 (3.8 Ϯ 3.2 g/mg creatinine) (*P Ͻ 0.05, at least 4 values/time point). ns, Not significant. Representative sequential SPECT imaging for 123 I-␤2-microglobulin handling in control mice (red circle) and a cisplatin-treated mouse reveals defective endocytic uptake at day 5 (blue inverted triangle), with partial recovery at day 12 (blue triangle). Note that the excretion defect (curve Ͼ7 min) persists at day 12. imaging for the renal uptake of 123 I-␤ 2 -microglobulin in individual mice, with a major defect of uptake at day 5 followed by partial recovery at day 12 (Fig. 6B) .
DISCUSSION
This report demonstrates the feasibility and validity of both static and dynamic SPECT imaging to investigate specific PT functions in conscious mice. To the best of our knowledge, this is the first report of dynamic SPECT renography in conscious mice demonstrating the feasibility of continuous monitoring of drug handling from the time of iv injection.
Our studies of 99m Tc-MAG3 showed a delayed tracer clearance and wider intra-assay variability in anesthetized mice, confirming the adverse impact of ketamine/xylazine on baseline renal function (14, 21, 22, 29) . To circumvent the need for anesthesia, we used a simple plastic holder, which was sufficient to immobilize the mice without discomfort during SPECT acquisition (Supplemental Fig. 1 ). The imaging of conscious mice allowed us to sequentially use three radiotracers to assess distinct PT functions in the same mice: 1) uptake of 99m Tc-DMSA to evaluate the functional cortex with high resolution; 2) dynamic 99m Tc-MAG3 SPECT to investigate the basolateral capture and apical secretion; and 3) processing of 123 I-␤ 2 -microglobulin to assess apical receptor-mediated endocytosis. We took advantage of the Clcn5 KO mice (7, 18, 28) to provide a proof of concept for the use of SPECT, which showed a severe defect in both apical receptor-mediated endocytosis and basolateral anionic uptake, without significant alteration of the apical secretion by PT cells.
The renal uptake of 99m
Tc-DMSA showed a progressive accumulation in mouse kidney cortex, matching standard curves reported in humans (16) . At the plateau phase, 99m Tc-DMSA SPECT yields a millimetric delineation of the cortex, sufficient to identify a local area of parenchymal damage, as documented by the experimental infarction model (Fig. 2, A  and B) . The procedure has a low interassay variability, which supports its usefulness for repetitive and long-term biodistribution studies, as well as longitudinal studies (e.g., evaluation of toxicity following treatment) in the same mice.
The dynamic SPECT quantification of ␤ 2 -microglobulin renal uptake provided the first in vivo time course of PT receptor-mediated endocytosis in conscious mice. The radiolabeled LMW protein is freely filtered by the glomeruli, avidly captured in the renal cortex, and rapidly degraded with subsequent release of the radiotracer and residual peptide/amino acids to peritubular capillaries (2) . The compartmental analysis of 123 I-␤ 2 -microglobulin biodistribution (Supplemental Fig. 2 ) enabled us to determine a GFR of 0.22 Ϯ 0.02 ml/min, similar to that reported previously by using FITC-inulin clearance (20) . The usefulness of SPECT to evaluate PT function is further demonstrated by the Clcn5 KO mice, characterized by defective endocytosis due to the internalization of the multiligand receptors, megalin and cubilin (7, 18) . Our data show that the defective PT apical endocytosis previously evidenced by ex vivo counting (7) is confirmed by noninvasive in vivo SPECT of 123 I-␤ 2 -microglobulin uptake. Despite similar GFR, the tubular reabsorption of 123 I-␤ 2 -microglobulin is strongly impaired in Clcn5 Y/Ϫ mice, with altered metabolization in PT and subsequent loss in the urine, mostly as native 123 I-labeled protein.
Similarly to ␤ 2 -microglobulin, the renal handling of 99m Tc-DMSA has been regarded as an indicator of PT dysfunction in human and animal models (1, 25) . For example, treatment of rats with Na-maleate induces a typical renal Fanconi syndrome, with marked reduction of 99m Tc-DMSA uptake (19) . In our study, SPECT quantification of 99m Tc-DMSA capture shows that inactivation of Clcn5 is associated with a lack of tracer accumulation in the renal cortex, suggesting a severe defect in PT basolateral function. It is likely that the residual signal detected in the pelvis of Clcn5 Y/Ϫ mice represents a small glomerular filtration of 99m Tc-DMSA (17) . The basolateral uptake of 99m Tc-DMSA from peritubular capillaries into S3 PT cells is mediated by the Na ϩ /dicarboxylate cotransporter NaDC3 (SLC13A3) (4, 13) (Fig. 1) . Of note, the coexpression of nonconducting fragments of ClC-5 with NaDC transporters alters their translation and/or trafficking in Xenopus laevis oocytes, resulting in decreased surface expression (15) . The severe deficit in both apical and basolateral SPECT uptake reported here further demonstrates that the functional loss of ClC-5 induces a generalized intracellular trafficking in PT cells (7, 18) .
Renal scintigraphy with 99m Tc-MAG3, a radiolabeled analog of p-aminohippurate, can provide excellent image quality even with severe renal failure (10) . For instance, 99m Tc-MAG3 imaging detected changes in renal function in anesthetized mice as early as 5 h following ischemia-reperfusion injury (22) . A model for 99m Tc-MAG3 secretion by PT cells has recently been proposed, based on in vitro transport experiments in X. laevis oocytes (24) (Fig. 1) .
99m Tc-MAG3 is intracellularly accumulated through the basolateral organic anion transporter OAT1 that is expressed in all PT segments (4). The molecular counterpart of 99m Tc-MAG3 apical transport could involve the Na ϩ -dependent phosphate transporter NPT1 and/or the multidrug resistance protein MRP2 (5, 24) . Our results demonstrate that PT dysfunction caused by the functional loss of ClC-5 is not associated with a defect in 99m Tc-MAG3 renal handling. The contrast between the complete loss of 99m Tc-DMSA basolateral uptake and the preserved 99m Tc-MAG3 secretion in Clcn5 KO kidneys provides further evidence that these two pathways are functionally independent (24) and corroborates immunolocalization studies showing a distinct distribution of NaDC3 and OAT1 in PT segments (4). Additional SPECT studies using mouse models invalidated for distinct organic anion transporters may help establish the metabolic pathways handling these particular radiotracers, as well as other drugs and metabolites.
In conclusion, SPECT analysis represents a new approach to characterize the renal PT function in conscious mice, based on acute and/or repetitive biodistribution studies using distinct radiolabeled tracers. Two limitations cannot be ignored. First, the spatial resolution of SPECT, being limited to the millimetric range, cannot compete with rapidly evolving live-microscopy methods (6) . Second, although SPECT offers a temporal resolution of 5-10 s for pharmacokinetic studies, this may not be sufficient to explore faster functions such as organelle activation or intracellular trafficking. Nevertheless, the development of creative approaches dedicated to small-animal imaging will permit further functional investigations of transgenic mouse strains, with relevance for renal physiology or disease mechanisms.
